Asset Allocation

As of June 30, 2026.
Type % Net
Cash 94.92%
Stock 3.83%
Bond 1.57%
Convertible 0.00%
Preferred 0.00%
Other -0.32%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 15.44%    % Emerging Markets: -0.12%    % Unidentified Markets: 84.68%

Americas 6.10%
6.09%
Canada 1.32%
United States 4.77%
0.01%
As of June 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 7.19%
United Kingdom 1.33%
5.72%
Finland 0.03%
France 0.12%
Germany 0.60%
Ireland 2.47%
Netherlands 1.35%
Norway 0.19%
Spain 0.12%
Sweden 0.55%
Switzerland 0.03%
0.00%
0.14%
United Arab Emirates 0.14%
Greater Asia 2.03%
Japan 0.07%
1.13%
Australia 1.00%
0.95%
Singapore 0.63%
Taiwan 0.32%
-0.12%
India -0.12%
Unidentified Region 84.68%

Bond Credit Quality Exposure

AAA 2.46%
AA 9.53%
A 1.19%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 86.82%
Short Term 0.00%
As of June 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
-1.24%
Materials
-0.24%
Consumer Discretionary
-4.41%
Financials
3.64%
Real Estate
-0.23%
Sensitive
18.21%
Communication Services
11.53%
Energy
-1.38%
Industrials
4.30%
Information Technology
3.75%
Defensive
2.02%
Consumer Staples
-6.81%
Health Care
6.65%
Utilities
2.19%
Not Classified
-2.08%
Non Classified Equity
-2.08%
As of June 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of June 30, 2026
Type % Net
Government 85.86%
Corporate 0.66%
Securitized 0.91%
Municipal 12.57%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
86.52%
Less than 1 Year
86.52%
Intermediate
2.01%
1 to 3 Years
1.64%
3 to 5 Years
0.00%
5 to 10 Years
0.36%
Long Term
11.48%
10 to 20 Years
0.00%
20 to 30 Years
11.48%
Over 30 Years
0.00%
Other
0.00%
As of June 30, 2026
View Bond Maturity Exposure
Start Trial